Summary of Purpose
This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.Read More →
The following dates are available for this trial. Trial information last updated on 9 June 2017.
|15 Feb 2017||9 Jun 2017||1 Dec 2018||1 Dec 2018||1 Jun 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Dr. Kanjana S Perera & Dr. Robert Hart